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Abstract
The hypothalamic lateral tuberal nucleus (NTL) can be recognized in man and higher primates, only. The function of this nucleus is 
unknown, but the NTL is affected in a variety of human neurodegenerative diseases, including Huntington’s disease (HD) and 
Alzheimer’s disease. In the present study we demonstrate an abundant presence of somatostatin 1-12 (SST1-12) immunoreactivity in 
both neurites and perikarya of the NTL. This immunoreactivity could be visualized best after microwave pretreatment. In HD brains, NTL 
SST1-12 immunoreactivity was greatly reduced, providing further evidence of the presence of SST1-12 as an intrinsic neuropeptide in 
the NTL. Although striatal SST neurons escape destruction in HD, our study demonstrates that not all SST neurons are resistant to the 
degenerative process in this disease.
Keywords: Human hypothalamus; Huntington’s disease; Nucleus tuberalis lateralis (NTL); Somatostatin; Microwave pretreatment
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X. Introduction
The lateral tuberal nucleus (nucleus tuberalis lateralis, 
NTL) is located in the basolateral tuberal hypothalamic 
region of man and higher primates [7,23]. Until recently, 
the nucleus could only be defined by cytoarchitectonie
itscriteria, i.e. by the characteristic size and shape 
neurons. These are triangular, polygonal, or rounded neu-
rons, with a diameter of about 25 |xm and an eccentrically
. The NTL is surrounded by tuberomam-
milary nucleus (TMN) that contains much larger, irregu­
larly bordered, darkly (cresyl violet) staining neurons, that 
are easily from NT I
H i
IS Ic. chemical anatomy
NTL. In infant hypothalamus, Najimi et al. found a
ies of monkey brains revealed binding sites for corti­
cotropin releasing hormone [13], muscarinic 
receptors [5], benzodiazepine receptors [26], W-methyl-D-
(NMDA) and a-amino-3-hydroxy-5-methyl-4- 
isoxazole-propionic acid (AMPA) receptors [10], as well as 
somatostatin receptors (in high densities) [20]. The latter 
observation, together with the presence of SST mRNA in 
the NTL [12] reinforced the notion that the NTL contains 
somatostatinergic interneurons [16].
by anti-soma-our group reporte 
tostatin 1-28 (antiserum S309) and anti-somatostatin 1-12
in the adult NTL [17]. Microscopically this staining 
of the NTL appeared to be rather diffuse with only very
rf e w
well staining basket-like axon endings were found around 





medial tuberal nuclei [16], probably
subnuclei of the NTL. In addition, LHRH fibers could
visiu in these structures [15], Autoradiographic stud-
* Correponding author. Fax; 4 31 (24) 354-1122.
s i ve soim innervation








neuronal is a very characteristic neuropathological
feature of Huntington’s disease [9], NTL immunoreactivity
will be significantly decreased in these patients,
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2. Materials and methods
2.1. Subjects and tissue
The hypothalami of 7 HD patients and 7 individually 
sex- and age-matched control subjects were studied. All 
patients were members of known HD families and suffered 
from progressive chorea and dementia. On autopsy in all 
cases striatal, particularly caudate atrophy with neuronal 
loss and astrocytosis was noted. The sizes of the CAG 
trinucleotide repeats in the IT15-gene, on the basis of 
which the diagnosis of Huntington’s disease can be made, 
could not be determined in these formalin-fixed brains 
[24]. The controls were free of neurological or psychiatric 
disease. Clinico-pathological information on patients and 
tissues is summarized in Table 1. The hypothalamic blocks 
were dissected coronally, fixed in 4% v / v  formaldehyde, 
embedded in paraffin, serially sectioned at 15 (xm or 6 (Jim 
(Table 1) and mounted on chrom-alum gelatin-coated glass 
slides by 0.5% bovine serum albumin (Sigma).
2.2. Antisera
To detect somatostatin neurons, rabbit polyclonal anti- 
serum S320 (21-10-81) that was raised in rabbits against 
the somatostatin-fragment 1 -12  following conjugation to 
bovine serum albumin was used [1-4,14,18]. Reacting 
epitopes were found by radioimmunoassay (RIA) to be 
located on amino acids 5 to 12 [ 18], No cross reactivity by 
adsorption experiments was found with the following pep­
tides: Leu-enkephalin, Met-enkephalin, ß-endorphin, Sub­
stance P, Dynorphin(l-13), VIP, CCK, Eledoisin, Neu­
rotensin, Vasopressin, Neuropeptide Y, Physalaemin, and
S-sleep inducing peptide [4]. Crossreactivity of S320 with 
SST fragments, other than S S T 1-12  was tested in RIAs; 
reactivity with SST 15-28 was absent and minimal (0.01%) 
with SST1-28 [I]. Dot spotting of different SST frag­
ments, followed by immunocytochemistry, showed some 
crossreactivity of S320 with SST 1-14, 1-28 and 4 -2 8  but 
not with 15-28 [18].
2.3. Microwave pretreatment o f  tissues
Tissue sections were deparaffinized in xylene, trans­
ferred to 99% ethanol and rehydrated. Microwave heating 
was performed according to an adapted protocol based 
upon Shi et al. [11,21]. Briefly, sections were transferred to 
a plastic coupling jar containing 0.05 M citrate buffer 12, 
pH 4. The jars were subsequently placed in the middle of a 
Miele Electronic M696 microwave oven operating at a 
frequency of 2450 MHz set at a temperature of 90°C. The 
temperature of the fluid did not exceed 90°C as measured 
with a Miele microwave standard thermo-probe. Heating 
took place in two 5 min cycles with an interval of 1 min in 
between to check the fluid level in the jar and to change 
the position of the jar to prevent local differences in 
heating of the fluid. The jar was allowed to cool for 5 min 
before sections were rinsed in distilled water and placed in 
Tris-buffered saline (TBS) after which immunocytochemi- 
cal incubation was performed.
2.4. Immunocytochemistry
Unless mentioned otherwise, incubations took place at 
room temperature. Mounted sections were washed in 0.05 






( m / f )
Age at onset
(yrs)





C ontr  ols
1 AH 1255 30 f Ml 24 6 Acute death f.u.r.
2 A88I72 42 f w* 6 15 Lung-embolism
3 S26087 63 m 7 15 Bronchial carcinoma
4 A4725 n iI  M f w* 21 6 Endocarditis lenta
5 S 19490 73 m 15 Myocardial infarct
6 S32287 77 f - 6 15 Breast carcinoma
7 A82175 85
mean 63.1 ±  20.0
m 16 6 Myocardial infarct
HD patients
8 CH76 27 f 19 24 15 General deterioration, pneumonia
9 C H 112 47 m 45 15 15 Accident
10 CH 99 64 m 46 8 15 General deterioration, pneumonia
11 CH 109 70 f 52 24 15 General deterioration, pneumonia
12 CH 104 74 f 62 2.5 15 General deterioration, pneumonia
13 CH 106 76 m 58 13.5 15 General deterioration, pneumonia
14 CH 114 80
mean 62.6 ±  19.1
ni 54 24 15 General deterioration, pneumonia
Abbreviations: HD, Huntington’s disease; yrs, years; m, male; 1', fema le; h, hours; f.u.r„ for unknown reason.
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Perhydrol (Merck) 0.2% Triton X-100 (Sigma) in TBS for 
30 min; incubated in 5% skimmed milk in TBS for 1 h in 
order to block non-specific antibody binding; incubation in 
S320 (1:2000) in 5% milk-TBS solution for 1 h was 
followed by overnight incubation at 4°C; incubated in 
biotinylated goat anti rabbit (GAR) immunoglobulins 
(Vector; 1:200) for 45 min and incubated with ABC 
(Vector; 1:200). Final colour development was performed 
with diaminobenzidine (DAB) which yielded a brown 
precipitate with minimal background staining. Sections 
were again dehydrated and coverslipped in Entellan.
As a test for method specificity, the primary and sec­




was used for absorption of possible crossreacting antibod­
ies from the S320 antiserum. Briefly, sheets of nitrocellu­
lose (NC) membranes (Schleicher and SchUll, Dassel, Ger­
many) with pore size 0.1 ¡xm (PH 75), were incubated 
0.2% w / v  gelatin (Merck) solutions, washed in distilled 
water, air dried and stored at room temperature. Either 
bovin serum albumin (Merck) or somatostatin 1-12 pep­
tide (Bissendorf biochemicals) was fixed onto the mem­
branes using formaldehyde (Merck; extra pure), buffered 
with 1 M phosphate, pH 7.4. S320 antiserum was submit­
ted to absorption three times by subsequent incubation of 
three prepared membranes, performed in 5% milk-TBS 
solution. In order to check antibody binding to the mem­
branes, they were stained using GAR and DAB according 
to methods described above. The antiserum that resulted 
from absorption was employed for immunocytochemistry 
on hypothalamic sections.
As the S320 antiserum was raised in rabbits, following 
conjugation of the SST peptide to bovine albumin as a 
carrier, we studied the possible crossreaction of anti-al- 
bumin antibodies. The method of Van der Sluis et al. [22]
.■ ; : *  t '
''■■V-iy. '■1 f •>ƒ
V
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1. Anti-somatostatin 1- 12 (S320) staining in the nucleus tuberalis 
lateralis (NTL), ventromedial nucleus (VMN) and bed nucleus of the stria 
tcrminalis (BST): control subject No. 2. Fx, fornix; TO, optic tract; Cl, 
internal capsule; TV, third ventricle. Bar ~  2.5 aim.
2.6. Neuron counts
Neuron counts in material have been published
previously [10]. Briefly, a systematic sampling method 
using an ocular micrometer grid was employed in com­
pletely and serially sectioned hypothalami. Only nucleated 
neurons were considered.
3. Results
3.1. S320 i reactivity in hypothalami
In the sections not by microwave, S320
yielded diffuse NTL staining that made the structure easily
maeroscopically (Fig. 1). Microscopically, 
this staining appeared to be present diffusely in the neu­
ropil, with very few cell bodies, and sparse positive fibers. 
However, clearly positive basket like axon endings around 
neurons were visible (Fig. 2A and B). In the TMN only a 
few isolated cell bodies of typical TMN neurons were 
positive. Medial to the NTL, close to the final descending
of the fornix thick neurites from unusually large 
neurons were stained by S320. The ventromedial nucleus 
(VMN) could clearly be distinguished by the presence of 
numerous thin beaded fibers, but no positive cell bodies 
were present (Fig. 3D). In the central nucleus of the bed 
nucleus of the stria terminalis (BST), many staining cell 
bodies and beaded fibers were visible. The stria terminalis 
also contained beaded fibers. The internal capsule showed 
some positive bundles of fibers and finally, the walls of 
vessels at the basis of the brainstem were weakly stained.
Microwave pretreatment resulted in an overall increase 
of staining intensity in all structures mentioned, without 
increasing non-specific background staining. In the NTL 
this pretreatment revealed many cell bodies of NTL neu-
144
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rons in hypothalami of all control subjects (Fig. 2B and 
D), as well as many positive beaded fibers. Control brains
intensities despite considerabledid not differ
differences in age at death or post-mortem interval. Stain­
ing in 6 and 15 thick sections did not differ. For 
unknown reasons, control subject No. 6 showed a higher 
background staining than others.
3.2. Absorption of anti-albumin antibodies from S320
Tissue sections that were stained by S320, following 
absorption to albumin, showed a staining pattern that was 
no different from the one with non-absorbed S320, except 
for the disappearance of staining in walls of vessels at the 
basis of the brainstem. This suggests that the immuno-
reactivity in vessel walls is due to anti-albumin 
in S320. Removal of anti-albumins did not lower back­
ground staining or NTL staining.
3.3. Absorption of anti SST1-12 antibodies from S320
Absorption of S320 to SST 1-12 precluded all staining 
as normally seen by S320 including NTL, TMN, VMN, 
BST and thick neurites close to the fornix. These findings 
support SST1-12 specific staining of these areas by S320. 
We only observed a low level of background staining and 
weakly positive endothelial staining, again consistent with 
the notion of endothelial anti-albumin staining.
3.4. S320 immunocytochemical reactivity in hypothalami
of HD patients
In HD hypothah
erally resulted in 
both neurons and fibers in
staining in 
alamic areas of all
HD patients. But in the NTL the staining intensity (with or 
without microwave pretreatment) was much lower than in 
controls (Fig. 3B and C; Table 2). Other structures, like 
VMN, BST and TMN stained with equal intensity in HD
controls. T amount of extremely
stained neurites close to the fornix was decreased as well.
Three patients (Nos. 8, 10 and 13) did not show any NTI
at all (T 2). In
slight
P
;r three patients only 
was present (Table 2). In one 
staining still seemed to be partially 
already considerably less than in
(Fig. 3E and Table 2). This patient died 2 
of the choreic movements. The neuronal count was half of 
the control values. In general, higher staining was achieved 
in cases with more neurons preserved than in those with
fewer left, though the small numbers 




In the present immunocytochemical study, we opti­
mized the staining of the hypothalamic nucleus tuberalis 
lateralis (NTL) with anti-somatostatin 1-12 (S320) through 
microwave treatment and studied this staining in Hunting­
ton’s disease (HD) patients, to test the hypothesis that if 
SST is intrinsic to NTL neurons, NTL immunoreactivity 
will be decreased in HD patients. Sections that had been 
submitted to microwave heating clearly showed improved 
staining intensity and immunocytochemical reactivity in 
NTL cell bodies. In HD patients we found a consistent 
decrease of NTL SST 1-12  
some staining was present, this was confined to neuronal 
perikarya and not to fibers. A relation seemed to exist 
between the numbers of NTL neurons in HD patients and
but this phenomenon should be 
studied in a larger sample.
The S320 antiserum we used is directed against somato­
statin 1-12 which originates from the somatostatin frag­
ment SST 1-28. SST 1-28 is potentially cleaved into the 
N-terminal dodecapeptide SST I-12  and the C-terminal 
tetradecapeptide SST15-28, which was first isolated from 
hypothalamus, and inhibits growth hormone secretion [4]. 
Although little is known about the physiological actions of 
SST I-12, it has been shown to be as widely distributed 
throughout the central nervous system as SST 1-28 and 
SST 15-28 [4]. These fragments have been shown to sat­
isfy many criteria that characterize neurotransmitters [4]. 
Biochemical studies indicated that 
cleavage of SST 1-28 into S S T I-12  and SST15-28 occurs
in human and monkey neocortex [8]. 
might occur in the NTL, where we reported SST 1-28  
immunoreactivity previously [17]. Thus, NTL S S T I-12
o f thei mmunoreactivity may
native biologically active peptide, or a post mortem cleav­
age artifact of SST 1-28. It is unlikely that this represents 





is in vivo, our findings provide an extra clue that
s are synthesized in NTL neurons.pre-SST derived 
In addition, in situ hybridization studies o f neurons of the 
NTL demonstrated SST mRNA, again suggesting pi 
lion of this peptide by these neurons [12]. Furthermore, our 
findings of baskets of axon terminals around NTL neurons, 
stained by anti SST I-12 and SST1-28 [17] augments the
H e l i u m  i l l u m i n a i i m i w m w M d M i
Fig. 2. A D: ihc elTect or mierowuve pretreutmcnt: Control subject No. 2; anti-somatostatin 1-12 (S320) staining in the nucleus tuberalis lateralis (NTL). 
Note that sections that were not pretreaied (A and C) show diffuse staining of neuropil and basket-like axon endings (arrows) on NTL neurons, whereas 
pretreated sections (B and D ) showed a more intensive neuropil staining and clear imnumoreactivity in cell bodies (arrows) of NTL neurons. Bar *  to  |xm.
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immuno-Fig. 3. A and B: comparison of anti somatostatin 1~ 
reactivity in a control hypothalamus (control subject No. 2) (A) to HD 
(patient No. 10) (B). Note that in the control hypothalamus, subdivisions 
of the NTL are intensively stained by S320, whereas there is no staining 
at all in the NTL area o f the HD patient. Staining intensity of the 
ventromedial nucleus (VMN) does not differ. HD patient No. 10: S320 
immunoreactivity is absent in the NTL (C), whereas in (he VMN beaded 
fibers are still present (D). In III) patient No. 9 (E), who died only 2 
years alter the onset of the disease, some S320 iinmunoreactivity remains 
in NTL neurons and neuropil but hardly at all in fibers, All sections were 
pretreated by microwave healing. Fx, fornix; NTL. nucleus tuberalis 
lateralis; VMN, ventromedial nucleus; Cl. internal capsule; TO, optic 
traci; BST, bed nucleus of the stria terminalis; TV. third ventricle. 
Bars = 2.5 mm in A and B; 10 |xm in ( \  D and K.
autoi
i on . Tak
s o m a t os tati n ergi e n e u
, in our sections stained by anti S S T l-12  
(and in earlier studies by SST I-2 8  [17]), the NTL lacks 
any 2
structures.
12 staining was in
of NTL neurons after microwave pretreatment. Microwav 
ing is hypothesized to increase 1
m
contain 1 ?  4 «M»
e neurons may
'e to be rendered accès-
sible to enable the S320 antibodies to bind. Alternatively,
microwave heating may induce cleavage or modifications 
of SST peptides and thereby may ‘create’ S S T l-1 2  anti­
gen.
In Huntington’s disease (HD), the NTL is severely 
affected. Neuron numbers may be reduced to less than 
10000, depending on age of onset of the disease, while 
gliosis is prominent [9]. It has been suggested, that this 
NTL vulnerability is related to the high density of NMDA  
receptors in this nucleus [10]. Our results of attenuated 
S S T l-1 2  (S320) iinmunoreactivity in the NTL of HD
neurons in
structure are srate in the course
of SST 1 mmuno-
€tmd the
of the disease, 
neurons are r 
The
reactivity in patient nos. 8, 10 and 13
presence of similar neuron numbers in nos. 13 and 14
neurons s
tides before their actual disappearance, 
seem to be comparable to the findings of neostriatal neu­
rons in
prior to disappearing [19]. An alternative explanation for 
the decrease of S320 iinmunoreactivity prior to a strong 
reduction of neuron numbers, could be that the somato- 
statinergic neurons represent only a small subpopulation of  
NTL neurons, particularly vulnerable to degeneration, and 
therefore die first.
in the rat brain. It has been stated that the NTL is
Table 2
Comparison of S320 NTL staining intensity to NTL neuron numbers
Control/HD .SST staining 
intensity in NTL
Total number of 
NTL neurons
Control subjects
No. 1 “ k i | < ¿  o i | a  * > » | æ not performed
No. 2 *f" 4” 4" 64900
No. 3 45 800
No. 4 » • V * |x a not performed
No. 5 t í  í ' - j í -1 43 800
No. 6 y f c j i - W 64700
No. 7 56500
mean 55 140 J 10054
III) patients
No. 8 I P 6500
No. 10 CM 8900
No. 13 15 100
No. 14 u j f f l 16 200
No. 11 20200
No. 12 t r i j 'W * 23 700
No. 9 U f t j> 3 t  ) » | m 23 300
mean 16271 ±6723
Neuron counts have been published previously. HD, Huntington’s dis 
ease; NTL.,
en
" In 2 control subjects (Nos. 1 and 4) total cell numbers could not be 
counted as the NTL could not be fully retrieved.
»/¡■fflyf , none; + ,  little; + +  , moderate; +  + + ,  abundant.
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in man and higher primates, only [7]. The findings of 
anti-SST 1-12 staining in NTL neurons allows to test the 
hypothesis that the NTL neurons are present in rodent 
brain but that they are not grouped in a well defined 
nucleus. Moreover, in animal models of Huntington’s dis­
ease [25], besides striatal degeneration, NTL degeneration 
should be considered a measure of the likeness of the 
model to human disease.
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